quinoxalines has been researched along with pik 75 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horiguchi, M; Motomura, T; Oiso, Y; Sakai, H; Yamashita, C | 1 |
1 other study(ies) available for quinoxalines and pik 75
Article | Year |
---|---|
Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration.
Topics: Androstadienes; Animals; Cell Differentiation; Cell Line; Humans; Hydrazones; Lung; Male; Mice, Inbred ICR; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Regeneration; Stem Cells; Sulfonamides; Thiazolidinediones; Wortmannin | 2015 |